DBV Technologies (DBVT) Long-Term Investments (2015 - 2019)
DBV Technologies (DBVT) reported Long-Term Investments of $18.3 million for Q4 2019, up 165.03% year-over-year from $6.9 million in Q4 2018, and up 165.03% on a QoQ basis from $6.9 million in Q4 2018.
DBV Technologies (DBVT) has 5 years of Long-Term Investments data on file, last reported at $18.3 million in Q4 2019.
- Quarterly Long-Term Investments rose 165.03% year-over-year to $18.3 million in Q4 2019, while the trailing twelve-month figure through Dec 2019 was $18.3 million (up 165.03% YoY) and the FY2019 annual result came in at $18.3 million, up 165.03% from the prior year.
- Long-Term Investments improved to $18.3 million in Q4 2019 per DBVT's latest filing, from $6.9 million in the prior quarter.
- Across five years, Long-Term Investments topped out at $18.3 million in Q4 2019 and bottomed at $3.0 million in Q4 2016.
- The 5-year median for Long-Term Investments is $3.5 million (2017), against an average of $6.9 million.
- The widest annual swing landed in 2016, when Long-Term Investments decreased 0.26%; it then soared 165.03% in 2019.
- Tracing DBVT's Long-Term Investments over 5 years: stood at $3.0 million in 2015, then slipped by 0.26% to $3.0 million in 2016, then advanced by 19.66% to $3.5 million in 2017, then soared by 94.17% to $6.9 million in 2018, then soared by 165.03% to $18.3 million in 2019.
- Per Business Quant, the three latest DBVT Long-Term Investments figures stand at $18.3 million (Q4 2019), $6.9 million (Q4 2018), and $3.5 million (Q4 2017).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 505,194.89 |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 5.75 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 9.79 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 22.17 Mn |
| 10 | DBV Technologies | 8.00 Bn | 7.77 Bn | -3.90 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 18.25 Mn |
| Dec 31, 2018 | 6.89 Mn |
| Dec 31, 2017 | 3.55 Mn |
| Dec 31, 2016 | 2.96 Mn |
| Dec 31, 2015 | 2.97 Mn |